• 1
    Delecluse HJ,Anagnostopoulos I,Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 14131420.
  • 2
    Armstrong R,Bradrick J,Liu YC. Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: A case report. J Oral Maxillofac Surg 2007; 65: 13611364.
  • 3
    Assanasen T,Wannakrairot P,Keelawat S, et al. Extranodal malignant lymphoma of the upper aerodigestive tract: Prevalence of Epstien-Barr virus (EBV) infection in King Chulalongkorn Memorial Hospital. J Med Assoc Thai 2005; 88 (Suppl 4): S266S273.
  • 4
    Borrero JJ,Pujol E,Perez S, et al. Plasmablastic lymphoma of the oral cavity and jaws. AIDS 2002; 16: 19791980.
  • 5
    Brown RS,Campbell C,Lishman SC, et al. Plasmablastic lymphoma: A new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma. Clin Oncol (R Coll Radiol) 1998; 10: 327329.
  • 6
    Brown RS,Power DA,Spittle HF, et al. Absence of immunohistochemical evidence for human herpesvirus 8 (HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man. Clin Oncol (R Coll Radiol) 2000; 12: 194.
  • 7
    Chen YB,Yu H,Gillani A, et al. AIDS-associated plasmablastic lymphoma presenting at the insertion site of a peritoneal dialysis catheter. J Clin Oncol 2007; 25: 31763178.
  • 8
    Dawson MA,Schwarer AP,McLean C, et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation–treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica 2007; 92: e11e12.
  • 9
    Desai RS,Vanaki SS,Puranik RS, et al. Plasmablastic lymphoma presenting as a gingival growth in a previously undiagnosed HIV-positive patient: A case report. J Oral Maxillofac Surg 2007; 65: 13581361.
  • 10
    Flaitz CM,Nichols CM,Walling DM, et al. Plasmablastic lymphoma: An HIV-associated entity with primary oral manifestations. Oral Oncol 2002; 38: 96102.
  • 11
    Hausermann P,Khanna N,Buess M, et al. Cutaneous plasmablastic lymphoma in an HIV-positive male: An unrecognized cutaneous manifestation. Dermatology 2004; 208: 287290.
  • 12
    Jordan LB,Lessells AM,Goodlad JR. Plasmablastic lymphoma arising at a cutaneous site. Histopathology 2005; 46: 113115.
  • 13
    Lester R,Li C,Phillips P, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: A report of two cases. Leuk Lymphoma 2004; 45: 18811885.
  • 14
    Lin Y,Rodrigues GD,Turner JF, et al. Plasmablastic lymphoma of the lung: Report of a unique case and review of the literature. Arch Pathol Lab Med 2001; 125: 282285.
  • 15
    Panos G,Karveli EA,Nikolatou O, et al. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol 2007; 82: 761765.
  • 16
    Pantanowitz L,Doweiko JP,Braza J, et al. HIV-associated plasmablastic lymphoma following HAART-related immune reconstitution. HIV AIDS Rev 2007; 7: 2932.
  • 17
    Porter SR,Diz Dios P,Kumar N, et al. Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 730734.
  • 18
    Radhakrishnan R,Suhas S,Kumar RV, et al. Plasmablastic lymphoma of the oral cavity in an HIV-positive child. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100: 725731.
  • 19
    Rajagopal AS,Copson E,Addis B, et al. Plasmablastic lymphoma: A case of rectal disease with spinal cord compression. Leuk Lymphoma. 2006; 47: 26702673.
  • 20
    Schichman SA,McClure R,Schaefer RF, et al. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: A further expansion of the disease spectrum. Am J Hematol 2004; 77: 291295.
  • 21
    Sharma R,Abdou S,Plymyer MR, et al. Disseminated plasmablastic lymphoma. J Am Coll Surg 2004; 199: 654655.
  • 22
    Shuangshoti S,Assanasen T,Lerdlum S, et al. Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol 2008:34: 245247.
  • 23
    Tavora F,Gonzalez-Cuyar LF,Sun CC, et al. Extra-oral plasmablastic lymphoma: Report of a case and review of literature. Hum Pathol 2006; 37: 12331236.
  • 24
    Cattaneo C,Facchetti F,Re A, et al. Oral cavity lymphomas in immunocompetent and human immunodeficiency virus infected patients. Leuk Lymphoma. 2005; 46: 7781.
  • 25
    Chetty R,Hlatswayo N,Muc R, et al. Plasmablastic lymphoma in HIV+ patients: An expanding spectrum. Histopathology 2003; 42: 605609.
  • 26
    Colomo L,Loong F,Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004; 28: 736747.
  • 27
    Ferrazzo KL,Mesquita RA,Aburad AT, et al. EBV detection in HIV-related oral plasmablastic lymphoma. Oral Dis 2007; 13: 564569.
  • 28
    Folk GS,Abbondanzo SL,Childers EL, et al. Plasmablastic lymphoma: A clinicopathologic correlation. Ann Diagn Pathol 2006; 10: 812.
  • 29
    Lin O,Gerhard R,Zerbini MC, et al. Cytologic features of plasmablastic lymphoma. Cancer 2005; 105: 139144.
  • 30
    Teruya-Feldstein J,Chiao E,Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: A clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004; 15: 16731679.
  • 31
    Jaffe EHN,Stein H,Vardiman J. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
  • 32
    Carbone A,Gaidano G,Gloghini A, et al. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: A diagnostic dilemma. Ann Otol Rhinol Laryngol 1999; 108: 9599.
  • 33
    Teruya-Feldstein J. Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr Oncol Rep 2005; 7: 357363.
  • 34
    Miles RR,Raphael M,McCarthy K, et al. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group. Pediatr Blood Cancer, E-pub ahead of print.
  • 35
    Pantanowitz L,Dezube BJ. Editorial comment: Plasmablastic lymphoma—A diagnostic and therapeutic puzzle. AIDS Read 2007; 17: 448449.
  • 36
    Raez L,Cabral L,Cai JP, et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 1999; 15: 713719.
  • 37
    Aboulafia DM,Ratner L,Miles SA, et al. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019. Clin Lymphoma Myeloma 2006; 6: 399402.
  • 38
    Goedhals J,Beukes CA,Hardie D. HHV8 in plasmablastic lymphoma. Am J Surg Pathol 2008; 32: 172; author reply172–174.
  • 39
    Carbone A,Gloghini A,Gaidano G. Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004; 28: 12511252.
  • 40
    Jaffar SA,Pihan G,Dezube BJ, et al. Differentiating HIV-associated lymphomas that exhibit plasmacellular differentiation. HIV AIDS Rev 2005; 4: 4349.
  • 41
    Lee OJ,Kim KW,Lee GK. Epstein-Barr virus and human immunodeficiency virus-negative oral plasmablastic lymphoma. J Oral Pathol Med 2006; 35: 382384.
  • 42
    Borenstein J,Pezzella F,Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 2007; 51: 774777.
  • 43
    Simonitsch-Klupp I,Hauser I,Ott G, et al. Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 2004; 18: 146155.
  • 44
    Vega F,Chang CC,Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005; 18: 806815.
  • 45
    Serrano D,Carrion R,Balsalobre P, et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 2005; 33: 487494.
  • 46
    Re A,Cattaneo C,Michieli M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003; 21: 44234427.
  • 47
    Miralles P,Berenguer J,Ribera JM, et al. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 2007; 44: 167173.
  • 48
    Cioc AM,Allen C,Kalmar JR, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004; 28: 4146.
  • 49
    Deloose ST,Smit LA,Pals FT, et al. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005; 19: 851855.
  • 50
    Dong HY,Scadden DT,de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: An aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005; 29: 16331641.
  • 51
    Nasta SD,Carrum GM,Shahab I, et al. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 2002; 43: 423426.